Skip to main content
OpenTrials
Completed

NCT Number: NCT03562650

Text Message Treatment for Social Anxiety

This is an intervention study designed to evaluate a text message based safety behavior fading treatment for people with social anxiety disorder.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Florida State University, Department of Psychology

Tallahassee, Florida, 32306, United States

About this study

This study hopes to assess whether a month long text message based safety behavior fading protocol is effective in reducing safety behaviors and social anxiety symptoms. Over the course of four consecutive weeks, text messages will be sent to participants the first day of the study and every other day for four weeks (14 texts in total). These text messages will remind participants to either avoid using their three most engaged in safety behaviors (assessed at pre-treatment) or to stay present-focused. The past week frequency of the participants' safety behaviors will be assessed at the beginning of pre-treatment, post-treatment, and four week follow up assessments Participants will be asked to complete an additional online questionnaire for both a post-treatment and a 4-week post-treatment follow up assessment. We hypothesize that: 1) the safety behavior group will show a greater overall reduction in social anxiety symptoms, 2) that the safety behavior group will show a reduction in the frequency of safety behavior use, and 3) that the present-focused group will show an increase in mindfulness.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Social Phobia Inventory score > 29

Exclusion criteria

  • receiving therapy
  • changes in the past 4 weeks with medication for emotional difficulties
  • psychotic symptoms

Treatment and study plan

Safety Behavior Fading

Behavioral

Participants are asked to fade their three most common safety behaviors associated with their social anxiety

Present Centered

Behavioral

Participants are asked to try to increase their focus on the present.

Primary outcomes

  1. Social Phobia Inventory (SPIN)

    Time frame: Change in social anxiety symptoms from baseline to post treatment (4 weeks) and one month follow up (8 weeks)

    Self-report scale that measures Social anxiety symptoms. Scores range from 0 to 68 with higher scores indicating higher levels of social anxiety symptoms.

Secondary outcomes

  1. Subtle Avoidance Frequency Examination(SAFE)

    Time frame: Change in safety behavior use from baseline to post treatment (4 weeks) and one month follow up (8 weeks)

    Self report scale used to assess how often people use safety behaviors to cope with their anxiety. Scores range from 33 to 165. Higher total scores are associated with more frequent safety behavior use.

  2. Cognitive and Affective Mindfulness Scale-Revised (CAMS-R)

    Time frame: Change in mindfulness from baseline to post treatment (4 weeks) and one month follow up (8 weeks)

    Self-report used to measure mindfulness, including awareness of thoughts and feelings. Total scores range from 12 to 48 with higher scores indicating a greater ability to be mindful, present in the moment, and aware of thoughts and feelings.

Sponsors and collaborators

Lead sponsor

Florida State University

Other

Registry information

Official study title

Computerized Treatment for Social Anxiety

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Jun 19, 2018
Registry last updated
Jan 29, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.